Anna Wald

STD and AIDS Research Training Grant

National Institute of Allergy and Infectious Diseases · T32

Contact PI · $2.8M · University of Washington

University of Washington Vaccine and Treatment Evaluation Unit

National Institute of Allergy and Infectious Diseases · UM1

Contact PI · $26.6M · University of Washington

University of Washington (UW) Sexually Transmitted Infections (STI) Cooperative Research Center (CRC) - Syphilis Vaccine to Protect Against Local and Disseminated T. pallidum Infection

National Institute of Allergy and Infectious Diseases · U19

Contact PI · $10.6M · University of Washington

Therapeutic Use of HPV L1 Vaccine in Anogenital Neoplasia: VIVA Trial

National Cancer Institute · R01

PI · $4.6M · Fred Hutchinson Cancer Center

Intradermal, Fractional Dose of HPV Vaccines:

Principal investigator · Active not recruiting · Phase 4

University of Washington

HPV Vaccine Therapy in Interrupting Progression in Patients With High-Grade Vulvar or Anal Lesions

Principal investigator · Terminated · Phase 4

Fred Hutchinson Cancer Center

Effect of Tenofovir on Genital Herpes Simplex Virus (HSV) Shedding

Principal investigator · Completed · Phase 4

University of Washington

An Open-label Trial of the Effect of Valacyclovir on Plasma HIV-1 Levels Among HIV-1 Seropositive and HSV-1/2 Seronegative Persons

Principal investigator · Withdrawn

University of Washington